Astrana Health (NASDAQ:ASTH) Trading Down 4.8% – Should You Sell?

Astrana Health, Inc. (NASDAQ:ASTH)’s stock price dropped 4.8% on Wednesday . The company traded as low as $36.32 and last traded at $36.4710. Approximately 137,474 shares were traded during trading, a decline of 73% from the average daily volume of 501,517 shares. The stock had previously closed at $38.29.

Analyst Ratings Changes

ASTH has been the subject of a number of recent analyst reports. TD Cowen upped their target price on Astrana Health from $35.00 to $45.00 and gave the company a “buy” rating in a research report on Tuesday, May 12th. Needham & Company LLC upped their target price on Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research report on Friday, May 8th. BTIG Research reiterated a “buy” rating and set a $50.00 target price on shares of Astrana Health in a research report on Tuesday, June 2nd. Barclays upgraded Astrana Health from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $37.00 to $50.00 in a research report on Tuesday, May 26th. Finally, Zacks Research upgraded Astrana Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 11th. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $45.00.

Astrana Health Price Performance

The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.35 and a current ratio of 1.35. The company has a market cap of $2.22 billion, a price-to-earnings ratio of 65.33 and a beta of 1.00. The business has a fifty day moving average price of $34.58 and a 200 day moving average price of $27.44.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.74 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.The company had revenue of $965.10 million during the quarter, compared to analysts’ expectations of $949.21 million. During the same quarter in the previous year, the firm earned $0.42 EPS. Astrana Health’s revenue was up 55.6% on a year-over-year basis. As a group, research analysts anticipate that Astrana Health, Inc. will post 1.25 earnings per share for the current year.

Hedge Funds Weigh In On Astrana Health

Institutional investors and hedge funds have recently bought and sold shares of the company. Signaturefd LLC increased its holdings in Astrana Health by 57.9% in the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after purchasing an additional 388 shares in the last quarter. GAMMA Investing LLC increased its holdings in Astrana Health by 144.7% in the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after purchasing an additional 871 shares in the last quarter. Strs Ohio acquired a new position in Astrana Health in the 4th quarter worth about $40,000. Tower Research Capital LLC TRC increased its holdings in Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after purchasing an additional 3,517 shares in the last quarter. Finally, State of Wyoming acquired a new position in Astrana Health in the 2nd quarter worth about $132,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.